Neonatal abstinence syndrome refers to the signs and symptoms attributed to the cessation
of prenatal exposure (via placental transfer) to various substances. This Primer focuses on …

Background The prevalence of substance use, both prescribed and non‐prescribed, is
increasing in many areas of the world. Substance use by women of childbearing age …

BACKGROUND: Polysubstance use is common among opioid-using women, yet its
association with pharmacotherapy for neonatal abstinence syndrome (NAS) remains …

Opioids are potent analgesics used to manage pain in both young and old, but the
increased use in the pregnant population has significant individual and societal implications …

Background Parental substance misuse is a pervasive risk factor for a range of detrimental
outcomes for children across the life course. While a variety of interventions have been …

Purpose The purpose of this quality improvement project was to determine if non-
pharmacologic strategies such as a rooming-in approach to care for newborns at risk of …

Abstract Background Managing Abstinence in Newborns (MAiN) is an evidence-based, cost-
saving approach to caring for infants at risk of developing neonatal opioid withdrawal …

Multiple system components can be engaged to provide improved patient care for infants
with NAS and their caregivers.• Prenatal consultation between mothers taking long-acting …

Background: Perinatal substance exposure is an increasing concern in infants being cared
for in neonatal intensive care units. Current recommendations support nonpharmacologic …

Substance use disorder (SUD) during pregnancy, which includes opioid use disorder
(OUD), has developed into a significant medical and social concern, as it can cause a range …